{"output": [["Perosphere Pharmaceuticals Inc.", "COMP", "Appoint", "Robert S. Langer", "PERSON"], ["Robert S. Langer", "PERSON", "Is_Member_Of", "Perosphere's Scientific Advisory Board", "ORG"], ["Robert S. Langer", "PERSON", "Author", "more than 1400 scientific papers", "CONCEPT"], ["Robert S. Langer", "PERSON", "Has", "approximately 1275 issued and pending patents", "CONCEPT"], ["Robert S. Langer", "PERSON", "License", "to over 350 pharmaceutical companies", "COMP"], ["Robert S. Langer", "PERSON", "Serve", "as a member of the United States Food and Drug Administration\u2019s SCIENCE Board", "ORG/GOV"], ["Robert S. Langer", "PERSON", "Serve", "as the Chairman from 1999 to 2002", "TIME"], ["Robert S. Langer", "PERSON", "Receive", "the nation\u2019s two highest scientific honors", "CONCEPT"], ["Robert S. Langer", "PERSON", "Serve", "on the Board of Directors of PureTech Health plc", "COMP"], ["Robert S. Langer", "PERSON", "Serve", "on the Board of Directors of Kala Pharmaceuticals, Inc.", "COMP"], ["Robert S. Langer", "PERSON", "Serve", "on the Board of Directors of Moderna Therapeutics, Inc.", "COMP"], ["Robert S. Langer", "PERSON", "Serve", "as a director for Momenta Pharmaceuticals", "COMP"], ["Robert S. Langer", "PERSON", "Serve", "as a director for Alkermes plc", "COMP"], ["Robert S. Langer", "PERSON", "Serve", "as a director for Wyeth Pharmaceuticals", "COMP"], ["Robert S. Langer", "PERSON", "Serve", "as a director for Millipore Corporation", "COMP"], ["Perosphere Pharmaceuticals Inc.", "COMP", "Develop", "ciraparantag", "PRODUCT"], ["Ciraparantag", "PRODUCT", "Combine", "with the oral direct factor Xa inhibitors and low molecular weight heparin", "PRODUCT"], ["Ciraparantag", "PRODUCT", "Allow", "rapid re-establishment of a normal blood coagulation state", "CONCEPT"], ["Perosphere Pharmaceuticals Inc.", "COMP", "Focus", "on developing rescue medications", "CONCEPT"]], "published": "2018-01-08T18:17:00.000+02:00"}